Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Oman

Oman Articles

Industry

The desire of the government of Oman to contain costs in the medicines sector will be reflected in a change in the source of the country's finished pharmaceutical imports. Currently,... 2013-07-15


Industry

BMI View: Although it is one of the smallest healthcare markets in the Gulf Cooperation Council, Oman boasts a 10-year compound annual growth rate of 9% in US dollar terms, a figure... 2013-04-24


Industry

BMI View: Gulf Co-operation Council (GCC) governments will reinforce their stance on containing the price of locally-produced and imported medicines in the region's pharmaceutical market... 2013-04-09


More ARTICLES

Industry

BMI View: Oman's favourable business environment, attractive disease profile and increasing demand for more expensive medicines and medical treatments by the wider population will continue... 2013-03-12


Industry

BMI View: The effects of the Arab Spring in 2011 will continue to ensure the Omani government allocates a larger budget to the healthcare sector in the medium term. Post 2013, BMI expects... 2013-01-16


Industry

BMI View: Ageing populations and the rising burden of cardiovascular disease, obesity and diabetes in the Gulf Cooperation Council (GCC) region, against a backdrop of rewarding pharmaceutical... 2012-09-28


Industry

BMI View: Saudi Arabia's move to encourage investment by Indian companies comes after Aurobindo Pharma announced it has chosen Oman as the base for its operations in the Gulf Cooperation... 2012-06-06


Industry

BMI View: Governments in emerging markets will become increasingly involved in the regulation of pharmaceutical prices, especially in markets where the state accounts for a large percentage... 2012-02-28

Middle East & Africa InsightMiddle East & Africa Channels Middle East & Africa Countries